Showing posts with label stromal and oncogenic receptor tyrosine kinase (RTK). Show all posts
Showing posts with label stromal and oncogenic receptor tyrosine kinase (RTK). Show all posts
Thursday, April 25, 2013

FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors

›
In continuation of my update on Stivagra We know that,  Regorafenib  ( BAY 73-4506 , commercial name Stivarga) is an oral multi-kinas...